Healthcare Top Gainers: Teva Pharmaceutical Industries (NYSE:TEVA), NordionInc (NYSE:NDZ), Galena Biopharma (NASDAQ:GALE), Novavax (NASDAQ:NVAX)

Momenta Pharmaceuticals (MNTA) plunged about 12% after the U.S. Supreme Court decided to hear an appeal filed by Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) in a patent fight over top-selling multiple sclerosis drug Copaxone, a move that could deter generic manufacturers from introducing cheaper versions onto the market as soon as May. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shares after opening at $49.60 moved to $52.94 on last trade day and at the end of the day closed at $52.84. Company price to sales ratio in past twelve months was calculated as 2.45 and price to cash ratio as 47.96.Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) showed a positive weekly performance of 7.55%.

Analysts at Paradigm Capital boosted their target price on shares of NordionInc (USA) (NYSE:NDZ) from $10.00 to $11.75 in a research report issued to clients and investors on Monday, American Banking and Market News reports. Paradigm Capital’s price objective points to a potential upside of 12.87% from the stocks previous close. NordionInc (USA) (NYSE:NDZ) shares advanced 10.66% in last trading session and ended the day on $11.52.NDZ return on equity ratio is recorded as 72.50% and its return on assets is 49.90%. NordionInc (USA) (NYSE:NDZ) yearly performance is 73.76%.

Galena Bio pharma Inc (NASDAQ:GALE)’s shares dropped 6.29% to $2.22. Cohen Milstein Sellers & Toll PLLC on Mar. 28 said it is conducting an investigation to determine whether Galena Bio pharma and certain of its officers and directors made false and misleading statements and/or omissions in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. A class action lawsuit was filed in the U.S. District Court for the District of Oregon by another law firm on behalf of purchasers of the common stock of Galena Biopharma, Inc. (GALE) between November 6, 2013 and February 14, 2014, inclusive (the “Class Period”). Galena Biopharma Inc (NASDAQ:GALE) shares moved up 12.61% in last trading session and was closed at $2.50, while trading in range of $2.18 – 2.50. Galena Biopharma Inc (NASDAQ:GALE) year to date (YTD) performance is -49.60%.

Novavax, Inc. (NASDAQ:NVAX)’s shares jumped 4.92% to $4.45. The company on Mar. 10 reported a net loss of $14.1 million, or $0.07 per share, for the fourth quarter of 2013, compared to a net loss of $8.0 million, or $0.06 per share, for the fourth quarter of 2012. For the full year 2013, the net loss was $52.0 million, or $0.31 per share, compared to a net loss of $28.5 million, or $0.22 per share, for 2012. Novavax revenue in the fourth quarter of 2013 increased 92% to $8.7 million as compared to $4.6 million for the same period in 2012. Novavax, Inc. (NASDAQ:NVAX) weekly performance is 9.69%. On last trading day company shares ended up $4.53. Novavax, Inc. (NASDAQ:NVAX) distance from 50-day simple moving average (SMA50) is -19.51%. Analysts mean target price for the company is $11.20.